← Back to Search

Strain-Counterstrain Treatment for Piriformis Syndrome

N/A
Recruiting
Led By Mickey Lui
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 to 65 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre and post each treatment. there are 2 treatments, 1-2 weeks apart from one another.
Awards & highlights

Study Summary

This trial seeks an efficient, non-invasive treatment option for piriformis muscle-related pain.

Who is the study for?
This trial is for people aged 18-65 with lower back pain specifically from the piriformis muscle, confirmed by a physical exam. Participants must speak English and be able to attend two sessions in one month. It's not for pregnant individuals, those with certain back conditions like lumbar radiculopathy or spondylolisthesis, or those receiving other treatments like massage during the study.Check my eligibility
What is being tested?
The trial is testing Strain-Counterstrain treatment on the piriformis muscle as a non-invasive way to relieve lower back pain. This technique involves finding tender points and using specific positions to alleviate discomfort.See study design
What are the potential side effects?
Since Strain-Counterstrain is a gentle manual therapy technique, side effects are minimal but may include temporary discomfort at the site of treatment or mild soreness post-treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre and post each treatment. there are 2 treatments, 1-2 weeks apart from one another.
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre and post each treatment. there are 2 treatments, 1-2 weeks apart from one another. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Algometer - Change in pressure pain threshold
Secondary outcome measures
Change in Oswestry Disability Index
Change in Visual Analog Scale

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Piriformis Strain-CounterstrainExperimental Treatment1 Intervention
The treatment group will receive strain-counterstrain for the piriformis muscle.
Group II: Hamstring Strain-CounterstrainPlacebo Group1 Intervention
The sham group will receive strain-counterstrain treatment for the hamstring muscle.

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,958 Total Patients Enrolled
Mickey LuiPrincipal InvestigatorLoma Linda University Health

Media Library

Strain-Counterstrain treatment of piriformis muscle Clinical Trial Eligibility Overview. Trial Name: NCT05023005 — N/A
Low Back Pain Research Study Groups: Piriformis Strain-Counterstrain, Hamstring Strain-Counterstrain
Low Back Pain Clinical Trial 2023: Strain-Counterstrain treatment of piriformis muscle Highlights & Side Effects. Trial Name: NCT05023005 — N/A
Strain-Counterstrain treatment of piriformis muscle 2023 Treatment Timeline for Medical Study. Trial Name: NCT05023005 — N/A
Low Back Pain Patient Testimony for trial: Trial Name: NCT05023005 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the qualifications to be eligible for this experiment?

"The criteria for this trial are low back pain and an age between 18-65. A maximum of 30 participants can take part in the experiment."

Answered by AI

Is the population base of this experiment inclusive of elderly individuals?

"The parameters for this medical trial necessitates that potential enrollees are between 18 and 65 years old. Additionally, there exist 11 trials specifically designed for minors and 222 studies tailored to elderly individuals."

Answered by AI

Is recruitment still underway for this investigation?

"The clinical trial is currently open to new candidates, as indicated on the official website. The study was posted on July 1st 2023 and since then has been amended in February 16th of the same year."

Answered by AI

How many participants are enrolled in the current investigation?

"Affirmative. Clinicaltrials.gov's records detail that this medical experiment, which was initially posted on July 1st 2023, is actively seeking out participants. Approximately 30 patients need to be enrolled at a single clinical trial site."

Answered by AI

Who else is applying?

What state do they live in?
Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

I’ve tried pt. Opioids and injections over the counter treatments I suffer pain each day no relief.
PatientReceived 2+ prior treatments
~20 spots leftby May 2025